Placental structure in type 1 diabetes: relation to fetal insulin, leptin, and IGF-I.
OBJECTIVE
Alteration of placental structure may influence fetal overgrowth and complications of maternal diabetes. We examined the placenta in a cohort of offspring of mothers with type 1 diabetes (OT1DM) to assess structural changes and determine whether these were related to maternal A1C, fetal hematocrit, fetal hormonal, or metabolic axes.


METHODS
Placental samples were analyzed using stereological techniques to quantify volumes and surface areas of key placental components in 88 OT1DM and 39 control subjects, and results related to maternal A1C and umbilical cord analytes (insulin, leptin, adiponectin, IGF-I, hematocrit, lipids, C-reactive protein, and interleukin-6).


RESULTS
Intervillous space volume was increased in OT1DM (OT1DM 250 + or - 81 cm(3) vs. control 217 + or - 65 cm(3); P = 0.02) with anisomorphic growth of villi (P = 0.025). The placentas showed a trend to increased weight (OT1DM 690 + or - 19 g; control 641 + or - 22 g; P = 0.08), but villous, nonparenchymal, trophoblast, and capillary volumes did not differ. Villous surface area, capillary surface area, membrane thickness, and calculated morphometric diffusing capacity were also similar in type 1 diabetic and control subjects. A1C at 26-34 weeks associated with birth weight (r = 0.27, P = 0.03), placental weight (r = 0.41, P = 0.0009), and intervillous space volume (r = 0.38, P = 0.0024). In multivariate analysis of cord parameters in OT1DM, fetal IGF-I emerged as a significant correlate of most components (intervillous space, villous, trophoblast, and capillary volumes, all P < 0.01). By contrast, fetal insulin was only independently associated with capillary surface area (positive, r(2) = 6.7%; P = 0.02).


CONCLUSIONS
There are minimal placental structural differences between OT1DM and control subjects. Fetal IGF-I but not fetal insulin emerges as a key correlate of placental substructural volumes, thereby facilitating feedback to the placenta regarding fetal metabolic demand.
Nelson
Scott M
SM
Department of Reproductive and Maternal Medicine, University of Glasgow, Glasgow, U.K. s.nelson@clinmed.gla.ac.uk
Coan
Philip M
PM
Burton
Graham J
GJ
Lindsay
Robert S
RS
D052242:Adiponectin / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000473:pathology*; D005260:Female; D005312:Fetal Blood / Q000737:chemistry* / Q000502:physiology*; D005333:Fetus / Q000502:physiology; D005938:Glucocorticoids / Q000627:therapeutic use; D006442:Glycated Hemoglobin / Q000378:metabolism; D006400:Hematocrit; D006801:Humans; D007231:Infant, Newborn; D007328:Insulin / Q000097:blood*; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D020738:Leptin / Q000097:blood; D008431:Maternal-Fetal Exchange; D010920:Placenta / Q000473:pathology*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood*; D011384:Proinsulin / Q000097:blood
D052242:Adiponectin; D005938:Glucocorticoids; D006442:Glycated Hemoglobin; D007328:Insulin; D007334:Insulin-Like Growth Factor I; D020738:Leptin; D011384:Proinsulin
J Clin Endocrinol Metab. 2006 Dec;91(12):5090-4
17018652
Diabetes Care. 2003 Aug;26(8):2244-9
12882843
BJOG. 2000 Aug;107(8):1001-6
10955432
Eur J Obstet Gynecol Reprod Biol. 1996 Sep;68(1-2):75-82
8886685
Diabetologia. 1993 Oct;36(10):955-60
8243876
J Clin Endocrinol Metab. 1998 Feb;83(2):499-502
9467564
Am J Reprod Immunol. 1993 Sep-Oct;30(2-3):136-45
8311922
Clin Endocrinol (Oxf). 2004 Sep;61(3):353-9
15355452
Endocrinology. 1994 Mar;134(3):1509-14
8119193
Endocrinology. 1997 Dec;138(12):5248-55
9389508
Placenta. 2006 Apr-May;27(4-5):468-74
16009423
Rev Reprod. 2000 Jan;5(1):18-24
10711732
Histochemistry. 1994 Apr;101(4):277-85
7928411
Diabetes. 2007 Nov;56(11):2705-9
17666470
Placenta. 1998 Jul-Aug;19(5-6):371-7
9699957
Early Hum Dev. 2007 Jan;83(1):41-6
16750336
Cell. 1993 Oct 8;75(1):73-82
8402902
Placenta. 2003 Sep-Oct;24(8-9):819-25
13129678
Diabet Med. 2009 Sep;26(9):887-92
19719709
J Anat. 2000 Aug;197 ( Pt 2):263-74
11005718
Diabetes Care. 2008 Jun;31(6):1123-5
18339975
J Anat. 2009 Jul;215(1):60-8
19467150
J Physiol. 2009 Mar 15;587(Pt 6):1145-52
19188249
Placenta. 2009 Apr;30(4):361-7
19203792
J Clin Endocrinol Metab. 2003 Apr;88(4):1664-71
12679454
Endocrinology. 2005 Mar;146(3):1498-505
15564321
J Clin Endocrinol Metab. 2000 Nov;85(11):4266-9
11095465
Placenta. 1999 May;20(4):325-30
10329354
Circ Res. 2009 Mar 13;104(5):600-8
19168441
Biol Reprod. 2007 Feb;76(2):203-10
17021346
Diabetes. 2007 Nov;56(11):2697-704
17704300
J Endocrinol. 1999 Aug;162(2):227-35
10425460
Circ Res. 1998 Nov 16;83(10):1059-66
9815153
Diabetologia. 2002 Oct;45(10):1434-9
12378385
N Engl J Med. 1996 Oct 31;335(18):1363-7
8857020
Br J Obstet Gynaecol. 1986 Jan;93(1):31-5
3942705
J Clin Endocrinol Metab. 2003 Mar;88(3):1205-11
12629107
J Anat. 1987 Jun;152:173-87
3654368
J Physiol. 2008 May 1;586(9):2393-403
18325979
Placenta. 1985 Jan-Feb;6(1):69-81
3991476
Diabetologia. 2006 Jan;49(1):123-31
16344925
Am J Obstet Gynecol. 2006 Jun;194(6):1537-45
16731069
Biol Neonate. 1973;23(3):231-59
4773529